KOSDAQ · Healthcare · ₩138B
₩6,540-2.97%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.6% · as of 26.09.11
Among 15 신약 개발 peers
Quarterly Revenue Growth
“치료 성과가 실제 판매로 이어질 준비를 시작했어요.”
In the company's words · 2026 2분기 filing